InvestorsHub Logo
Followers 87
Posts 6641
Boards Moderated 1
Alias Born 09/18/2009

Re: None

Friday, 02/02/2024 1:54:05 AM

Friday, February 02, 2024 1:54:05 AM

Post# of 42748
Kite announces manufacturing process change to improve turnaround time for Yescarta CAR-T therapy. The improvement pales in comparison to what Gracell has demonstrated.

https://www.gilead.com/news-and-press/press-room/press-releases/2024/1/kite-receives-us-fda-approval-of-manufacturing-process-change-resulting-in-reduced-median-turnaround-time-for-yescarta-car-tcell-therapy